Evicenter
Xtandi (enzalutamide), All indications
Manufacturer
Astellas Pharma US, Inc.; Pfizer Inc.
Prescribing information
Xtandi (opens in a new tab)
Questions
66
Last updated

All questions

Safety: Xtandi (enzalutamide), all indications

14 questions · 3 sources

Safety

Does Xtandi prolong the QT interval?

What should be done after an Xtandi overdose?

Warnings

What are the contraindications for Xtandi?

What are the warnings and precautions for Xtandi?

Can Xtandi cause seizures?

“Seizure occurred in 0.6% of patients receiving XTANDI in eight randomized clinical trials. In these trials, patients with predisposing factors for seizure were generally excluded. Seizure occurred from 13 to 2250 days after initiation of XTANDI. Patients experiencing seizure were permanently discontinued from therapy, and all seizure events resolved. In a single-arm trial designed to assess the risk of seizure in patients with pre-disposing factors for seizure, 8 of 366 (2.2%) XTANDI-treated patients experienced a seizure. Three of the 8 patients experienced a second seizure during continued treatment with XTANDI after their first seizure resolved. It is unknown whether anti-epileptic medications will prevent seizures with XTANDI. Patients in the study had one or more of the following pre-disposing factors: the use of medications that may lower the seizure threshold (~ 54%), history of traumatic brain or head injury (~ 28%), history of cerebrovascular accident or transient ischemic attack (~ 24%), and Alzheimer’s disease, meningioma, or leptomeningeal disease from prostate cancer, unexplained loss of consciousness within the last 12 months, past history of seizure, presence of a space occupying lesion of the brain, history of arteriovenous malformation, or history of brain infection (all < 5%). Approximately 17% of patients had more than one risk factor. Advise patients of the risk of developing a seizure while receiving XTANDI and of engaging in any activity where sudden loss of consciousness could cause serious harm to themselves or others. Permanently discontinue XTANDI in patients who develop a seizure during treatment.” (opens the source at this quote in a new tab)

Note: The Prescribing Information pools its eight randomized, controlled trials across patients with CRPC (N = 3651), mCSPC (N = 754), and nmCSPC with high-risk BCR (N = 707).

Can Xtandi cause PRES (posterior reversible encephalopathy syndrome)?

Can Xtandi cause allergic reactions or facial swelling?

Note: The Prescribing Information pools its eight randomized, controlled trials across patients with CRPC (N = 3651), mCSPC (N = 754), and nmCSPC with high-risk BCR (N = 707).

Does Xtandi increase the risk of ischemic heart disease?

Note: The Prescribing Information names its five placebo-controlled trials as AFFIRM, PROSPER, PREVAIL, ARCHES, and EMBARK; ARCHES and EMBARK enrolled patients with castration-sensitive prostate cancer.

Does Xtandi increase the risk of falls and fractures?

Note: The Prescribing Information names its five placebo-controlled trials as AFFIRM, PROSPER, PREVAIL, ARCHES, and EMBARK; ARCHES and EMBARK enrolled patients with castration-sensitive prostate cancer.

Can Xtandi cause choking or trouble swallowing?

Side effects

Does Xtandi raise blood pressure?

Note: The Prescribing Information names its five placebo-controlled trials as AFFIRM, PROSPER, PREVAIL, ARCHES, and EMBARK; ARCHES and EMBARK enrolled patients with castration-sensitive prostate cancer.

What are the most common side effects of Xtandi?

Note: The five placebo-controlled trials in this pooled statement include trials in castration-sensitive prostate cancer (ARCHES and EMBARK) as well as CRPC (AFFIRM, PROSPER, and PREVAIL).

What lab abnormalities occur with Xtandi?

Note: Each table row lists XTANDI Grade 1-4, XTANDI Grade 3-4, placebo Grade 1-4, and placebo Grade 3-4 percentages, in that order, as in the table header.

What side effects have been reported with Xtandi since approval?